Impaired TGF-β signaling in patients with active systemic lupus erythematosus is associated with an overexpression of IL-22
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- TGF-β signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferationNature Immunology, 2012
- Role of Treg Cells and TGF-β1 in Patients with Systemic Lupus Erythematosus: A Possible Relation with Lupus NephritisImmunological Investigations, 2011
- Expressions of IL-22 in circulating CD4+/CD8+ T cells and their correlation with disease activity in SLE patientsClinical and Experimental Medicine, 2011
- Programmed Death-1 Ligand 1 Interacts Specifically with the B7-1 Costimulatory Molecule to Inhibit T Cell ResponsesImmunity, 2007
- Transforming Growth Factor-β Controls Development, Homeostasis, and Tolerance of T Cells by Regulatory T Cell-Dependent and -Independent MechanismsImmunity, 2006
- Transcriptional Regulation of Tristetraprolin by Transforming Growth Factor-β in Human T CellsJournal of Biological Chemistry, 2003
- Transforming growth factor-β in T-cell biologyNature Reviews Immunology, 2002
- Inflammation and TGFβ1: Lessons from the TGFβ1 null mouseResearch in Immunology, 1997
- Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory diseaseNature, 1992
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992